Moises Colin is currently the Senior Vice President of Global Quality at Balt since July 2019. Prior to this, Moises held the position of Vice President of Quality at Elixir Medical Corporation from September 2015 to June 2019. With extensive experience in quality engineering and management, Moises has also worked in roles such as Director of Quality Engineering and Manager at various companies including Accriva Diagnostics, ev3 Neurovascular/Covidien, MTI/ev3 Neurovascular, Boston Scientific, Guidant, and Medtronic. Moises holds a Bachelor of Science degree in Materials Engineering from California Polytechnic State University-San Luis Obispo.
Org chart
Teams
Offices
This person is not in any offices
Balt
1 followers
We are Balt. Physician-inspired innovations. Patient-focused solutions. For 45 years, Balt has been leading the way – collaborating with physicians and institutions to develop elegant neurovascular solutions. As the premier global neurovascular platform, always seeking to expand beyond boundaries, we are now bringing our innovation to the peripheral vascular space. We introduced the first neurovascular intervention device in 1977. Now, we offer the world’s broadest portfolio of medical devices for ischemic and hemorrhagic stroke, as well as devices for peripheral embolization. In 2015, we embarked on an ambitious journey and quadrupled our revenue and workforce, and that was only the beginning. Now, the Balt family includes more than 700 talented team members at 13 sites in 11 countries around the world. Be a part of our future: www.baltgroup.com
